HRMY
$33.84
Revenue | $186.04Mn |
Net Profits | $46.09Mn |
Net Profit Margins | 24.78% |
Harmony Biosciences Holdings Inc’s revenue jumped 16.08% since last year same period to $186.04Mn in the Q3 2024. On a quarterly growth basis, Harmony Biosciences Holdings Inc has generated 7.65% jump in its revenue since last 3-months.
Harmony Biosciences Holdings Inc’s net profit jumped 19.84% since last year same period to $46.09Mn in the Q3 2024. On a quarterly growth basis, Harmony Biosciences Holdings Inc has generated 297.66% jump in its net profits since last 3-months.
Harmony Biosciences Holdings Inc’s net profit margin jumped 3.24% since last year same period to 24.78% in the Q3 2024. On a quarterly growth basis, Harmony Biosciences Holdings Inc has generated 269.4% jump in its net profit margins since last 3-months.
EPS Estimate Current Quarter | 0.67 |
EPS Estimate Current Year | 0.67 |
Harmony Biosciences Holdings Inc’s earning per share (EPS) estimates for the current quarter stand at 0.67 - a 1216.67% jump from last quarter’s estimates.
Harmony Biosciences Holdings Inc’s earning per share (EPS) estimates for the current year stand at 0.67.
Earning Per Share (EPS) | 0.79 |
Harmony Biosciences Holdings Inc’s earning per share (EPS) jumped 5.33% since last year same period to 0.79 in the Q3 2024. This indicates that the Harmony Biosciences Holdings Inc has generated 5.33% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2024-04-30 | 0.6 | 0.67 | 11.67% |
2024-10-29 | 0.67 | 0.79 | 17.91% |
2024-08-06 | -0.06 | 0.2 | 433.33% |